装逼备忘录2020-03-26 10:27
生物科学股票今日表现(3/25)
$Immutep(IMMP)$ PFS breast data -52%
$ProQR Therapeutics(PRQR)$ interim analysis March 31
$Eloxx制药(ELOX)$ stops CF enrolment -16%查看全文
EvergreenHall未然2019-07-12 16:45
$ProQR Therapeutics(PRQR)$ 7月13 揭晓针对II型亚瑟综合征的1期实验结果。
去年的黑蒙症1期实验成功,股价翻了3倍。今年的实验结果也值得期待。II型亚瑟综合征的特征是:先天性,双侧感觉神经性听力损失,低频轻度至中度,高频率严重至深度; 完整的前庭反应; 和视网膜色素变性(RP)。RP是进...查看全文
ProQR Therapeutics(PRQR.US)盘前涨超12%报7.65美元。此前该公司宣布与礼来公司进行Aximer RNA编辑许可和研究合作,共同开发针对多达5个靶点的编辑寡核苷酸。ProQR将获得5000万美元,包括预付款和股权投资。 网页链接
$ProQR Therapeutics(PRQR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-24-064273 Act: 34 Size: 17 KB 网页链接
$ProQR Therapeutics(PRQR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001544784-24-000053 Act: 34 Size: 3 MB 网页链接
$ProQR Therapeutics(PRQR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-24-058436 Act: 34 Size: 41 KB 网页链接
$ProQR Therapeutics(PRQR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-24-050316 Act: 34 Size: 253 KB 网页链接
$ProQR Therapeutics(PRQR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-24-049095 Act: 34 Size: 25 KB 网页链接
$ProQR Therapeutics(PRQR)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001558370-24-003060 Act: 34 Size: 14 MB 网页链接
$ProQR Therapeutics(PRQR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-24-033735 Act: 34 Size: 49 KB 网页链接
$ProQR Therapeutics(PRQR)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-24-024357 Act: 34 Size: 24 KB 网页链接
$ProQR Therapeutics(PRQR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-022674 Act: 34 Size: 175 KB 网页链接
$ProQR Therapeutics(PRQR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-012561 Act: 34 Size: 175 KB 网页链接